FTC
requires Lupin, Gavis to
divest ***** for
deal approval
Feb 19 (Reuters) - Lupin Ltd and
Gavis Pharmaceuticals LLC must
divest two
***** for the Indian generic drugmaker's proposed $880 million acquisition of
Gavis to go through, the U.S. Federal Trade Commission said.
